U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840899) titled 'CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury' on Feb. 17.

Brief Summary: The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI).

Participants will take Epidiolex (purified CBD) for 90 days

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Supra-sacral Spinal Cord Injury Spinal Cord Injury Urinary Incontinence

Intervention: DRUG: CBD

Twice daily 100mg cannabidiol (CBD)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: University of Wisconsin, Madison

Disclaimer: Curated by HT...